USE OF CAMPTOTHECIN DERIVATES FOR THE TREATMENT OF PROLIFERATIVE DISEASES IN A FIXED DOSING REGIMEN

摘要

Topoisomerase I inhibitors preferably the camptothecin derivative gimatecan, are administered for the treatment of proliferative diseases according to a once every three day fixed dosing regimens. Furthermore, the invention provides the use of topoisomerase inhibitors to manufacture a medicament for the treatment of a proliferative disease which can be used in a fixed dose treatment regimen.